The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPLP.L Regulatory News (PLP)

  • There is currently no data for PLP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of Placing

7 May 2020 14:36

RNS Number : 3168M
Polypipe Group PLC
07 May 2020
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN ARE RESTRICTED AND ARE NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, RELEASE OR DISTRIBUTION WOULD BE UNLAWFUL.

 

FURTHER THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN ARE FOR INFORMATION PURPOSES ONLY AND IS NOT AN OFFER OF SECURITIES IN ANY JURISDICTION. PLEASE SEE THE CAUTIONARY STATEMENT AT THE END OF THIS ANNOUNCEMENT.

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION.

 

For immediate release

 

7 May 2020 

Polypipe Group plc

("Polypipe" or the "Company")

 

Results of Placing

Polypipe announces the successful completion of the non-pre-emptive placing of ordinary shares in the capital of the Company announced this morning (the "Placing").

A total of 26,966,300 new ordinary shares in the capital of the Company (the "Placing Shares") have been placed by Deutsche Bank AG, London Branch ("Deutsche Bank") and Numis Securities Limited ("Numis") acting as Joint Bookrunners, raising gross proceeds of approximately £120.0 million. The Placing Shares have been issued at a price of 445 pence per Placing Share (the "Placing Price"). The Placing Shares being issued represent, in aggregate, approximately 13.4 per cent. of Polypipe's issued ordinary share capital prior to the Placing.

The Placing Price of 445 pence represents a 7.7 per cent. discount to the closing mid-market share price of 482 pence on 6 May 2020, and a 3.1 per cent. discount to the middle market price at which time the Company and Joint Bookrunners agreed the Placing Price.

Polypipe consulted with a number of its major shareholders prior to the Placing in order to adhere to the principles of pre-emption through the allocation process. The Company is pleased by the strong support it has received from existing shareholders and new investors.

Applications have been made to the Financial Conduct Authority (the "FCA") and the London Stock Exchange plc (the "London Stock Exchange") for the admission of the Placing Shares to the premium listing segment of the Official List of the FCA and to trading on the main market for listed securities of the London Stock Exchange (together, "Admission"). Admission is expected to take place at 8:00 a.m. (London time) on 13 May 2020. The Placing is conditional, inter alia, upon Admission becoming effective and the placing agreement between the Company and the Joint Bookrunners not being terminated.

The Placing Shares will, when issued, be credited as fully paid and rank pari passu with the existing ordinary shares of £0.001 each in the capital of the Company, including, without limitation, the right to receive all future dividends and distributions declared, made or paid after the date of issue of the Placing Shares.

Total voting rights

The Company's enlarged issued share capital immediately following Admission will comprise 227,966,162 ordinary shares. The Company currently holds 2,504 shares in treasury, which do not carry voting rights, and therefore, following Admission, the total number of voting rights in the Company will be 227,963,658. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the Disclosure Guidance and Transparency Rules.

Director participation in the Placing

Certain directors of the Company have agreed to acquire Placing Shares in the Placing in the amount opposite his/her name in the table below:

Name

Number of Placing Shares

Ronald Marsh

33,707

Martin Payne

23,595

Paul James

5,617

Lisa Scenna

10,112

Mark Hammond

2,247

Paul Dean

898

 

Smaller related party transactions

Standard Life Aberdeen is a substantial shareholder in the Company for the purposes of the Listing Rules as a result of being entitled to exercise, or to control the exercise of, over 10 per cent. of the votes able to be cast at general meetings of the Company. It is therefore considered to be a related party for the purposes of Chapter 11 of the Listing Rules. Standard Life Aberdeen has agreed to acquire 2,089,313 Placing Shares in the Placing, amounting to a total subscription of approximately £9.3 million under, and on the terms and conditions, of the Placing. Under Listing Rule 11.1.10R, the participation in the Placing by Standard Life Aberdeen constitutes a "smaller" related party transaction.

Enquiries: 

Polypipe

Martin Payne, Chief Executive Officer

Paul James, Chief Financial Officer

 

Deutsche Bank (Joint Global Coordinator and Joint Corporate Broker)

Charles Wilkinson / Simon Hollingsworth / Mark Hankinson

+44 (0) 1709 770 000

 

 

 

+44 (0) 20 545 8000

 

Numis Securities (Joint Global Coordinator and Joint Corporate Broker)

Heraclis Economides / Richard Thomas / Ben Stoop / Alasdair Abram

 

Moelis

Mark Aedy / Liam Beere

 

Brunswick

Nina Coad / Charles Pretzlik

 

 

+44 (0) 20 7260 1000

 

 

 

 

+44 (0) 20 7634 3500

 

 

+44 (0) 20 7404 5959

   

IMPORTANT NOTICES

No action has been taken by the Company, Deutsche Bank or Numis or any of its or their respective affiliates, or any of its or their respective agents, directors, officers or employees that would permit an offer of the Placing Shares or possession or distribution of this Announcement or any other offering or publicity material relating to such Placing Shares in any jurisdiction where action for that purpose is required. Persons into whose possession this Announcement comes are required by the Company and the Banks to inform themselves about, and to observe, such restrictions.

No prospectus will be made available in connection with the matters contained in this Announcement and no such prospectus is required (in accordance with the Prospectus Regulation) to be published. Persons needing advice should consult a qualified independent legal adviser, business adviser, financial adviser or tax adviser for legal, financial, business or tax advice.

THIS ANNOUNCEMENTAND THE INFORMATION CONTAINED IN IT, IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA (COLLECTIVELY, THE "UNITED STATES"), AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, RELEASE OR DISTRIBUTION WOULD BE UNLAWFUL. FURTHER, THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND IS NOT AN OFFER OF SECURITIES IN ANY JURISDICTION. THIS ANNOUNCEMENT HAS NOT BEEN APPROVED BY THE LONDON STOCK EXCHANGE, NOR IS IT INTENDED THAT IT WILL BE SO APPROVED.

This Announcement or any part of it does not constitute or form part of any offer to issue or sell, or the solicitation of an offer to acquire, purchase or subscribe for, any securities in the United States, Canada, Australia, the Republic of South Africa or Japan or any other jurisdiction in which the same would be unlawful. No public offering of the Placing Shares is being made in any such jurisdiction.

The securities referred to herein have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act"), or under the securities laws of any state or other jurisdiction of the United States, and may not be offered or sold directly or indirectly in or into the United States absent registration under the Securities Act or pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with the securities laws of any state or any other jurisdiction of the United States. The Placing Shares are, being offered and sold (a) outside the United States in offshore transactions as defined in, and pursuant to Regulation S under the Securities Act ("Regulation S") or (b) in the in the United States only to persons reasonably believed to be "qualified institutional buyers" (as defined in Rule 144A of the Securities Act) ("QIBs") in transactions not involving any "public offering" within the meaning of Section 4(a)(2) of the Securities Act and/or pursuant to an exemption from, or transaction not subject to, the registration requirements of the Securities Act. A Placee (as defined below) and any the prospective beneficial owner of the Placing Shares is, and at the time the placing shares are subscribed for will be, (i) outside the United States and subscribing for the placing shares in an "offshore transaction" as defined in, and in accordance with, Regulation S; or (ii) (a) a QIB and (b) subscribing for the placing shares pursuant to an exemption from, or in a transaction not subject to, the registration requirements under the Securities Act. No public offering of securities is being made in the United States. No money, securities or other consideration from any person inside the United States is being solicited and, if sent in response to the information contained in this Announcement and does not meet the criteria above, will not be accepted.

Members of the public are not eligible to take part in the Placing. In the European Economic Area ("EEA") and the United Kingdom, this Announcement is directed only at and may only be communicated to persons who are "qualified investors" within the meaning of Article 2(e) of Prospectus Regulation (Regulation (EU) 2017/1129) ("Qualified Investors"). In the United Kingdom, this Announcement is directed only at Qualified Persons who are also (i) persons having professional experience in matters relating to investments who fall within the definition of "investment professionals" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order"); (ii) high net worth bodies corporate, unincorporated associations and partnerships and trustees of high value trusts as described in Article 49(2) of the Order; or (iii) persons to whom it may otherwise lawfully be communicated (together, "Relevant Persons"). Any investment or investment activity to which the Announcement relates is only available to and will only be engaged with Relevant Persons. This announcement must not be acted on or relied on by persons who are not Relevant Persons.

Certain statements contained in this Announcement constitute "forward-looking statements" with respect to the financial condition, performance, strategic initiatives, objectives, results of operations and business of the Company. All statements other than statements of historical facts included in this Announcement are, or may be deemed to be, forward-looking statements. Without limitation, any statements preceded or followed by or that include the words "targets", "plans", "believes'", "expects", "aims", "intends", "anticipates", "estimates", "projects", "will", "may", "would", "could" or "should", or words or terms of similar substance or the negative thereof, are forward-looking statements. Forward-looking statements include statements relating to the following: (i) future capital expenditures, expenses, revenues, earnings, synergies, economic performance, indebtedness, financial condition, dividend policy, losses and future prospects; and (ii) business and management strategies and the expansion and growth of the Company's operations. Such forward-looking statements involve risks and uncertainties that could significantly affect expected results and are based on certain key assumptions. Many factors could cause actual results, performance or achievements to differ materially from those projected or implied in any forward-looking statements. The important factors that could cause the Company's actual results, performance or achievements to differ materially from those in the forward-looking statements include, among others, economic and business cycles, the terms and conditions of the Company's financing arrangements, foreign currency rate fluctuations, competition in the Company's principal markets, acquisitions or disposals of businesses or assets and trends in the Company's principal industries. Due to such uncertainties and risks, you are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof. In light of these risks, uncertainties and assumptions, the events described in the forward-looking statements in this Announcement may not occur. The forward-looking statements contained in this Announcement speak only as of the date of this Announcement. The Company, its Directors, Deutsche Bank and Numis each expressly disclaim any obligation or undertaking to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, unless required to do so by applicable law or regulation, the Listing Rules, MAR, the DTRs, the rules of the London Stock Exchange or the FCA.

Deutsche Bank, which is subject to the supervision by the European Central Bank and by BaFin, Germany's Federal Financial Supervisory Authority, and is subject to limited regulation in the United Kingdom by the Prudential Regulation Authority and the FCA and Numis, which is authorised and regulated by the FCA are acting solely for the Company and no one else in connection with the Placing, the content of this Announcement and other matters described in this Announcement. Deutsche Bank and Numis will not regard any other person as their respective clients in relation to the Placing, the content of this Announcement and other matters described in this Announcement and will not be responsible to anyone (including any Placees) other than the Company for providing the protections afforded to their respective clients or for providing advice to any other person in relation to the Placing, the content of this Announcement or any other matters referred to in this Announcement.

This Announcement has been issued by and is the sole responsibility of the Company. No representation or warranty, express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by Deutsche Bank, Numis or by any of its or their respective affiliates or any of its or their respective directors, officers, employees, agents or advisers as to, or in relation to, the accuracy or completeness of this Announcement or any other written or oral information made available to or publicly available to any interested party or its advisers, and any liability therefore is expressly disclaimed.

This Announcement does not constitute a recommendation concerning any investor's options with respect to the Placing. The price of shares and any income expected from them may go down as well as up and investors may not get back the full amount invested upon disposal of the shares. Past performance is no guide to future performance. The contents of this Announcement are not to be construed as legal, business, financial or tax advice. Each investor or prospective investor should consult his, her or its own legal adviser, business adviser, financial adviser or tax adviser for legal, financial, business or tax advice.

Any indication in this Announcement of the price at which ordinary shares have been bought or sold in the past cannot be relied upon as a guide to future performance. No statement in this Announcement is intended as a profit forecast or estimate for any period and no statement in this Announcement should be interpreted to mean that earnings, earnings per share or income, cash flow from operations or free cash flow for the Company, as appropriate, for the current or future years would necessarily match or exceed the historical published earnings, earnings per share or income, cash flow from operations or free cash flow for the Company.

In connection with the Placing, each of the Banks and any of their respective affiliates, may take up a portion of the shares of the Company in the Placing as a principal position and in that capacity may retain, purchase or sell for its own account such shares and other securities of the Company or related investments and may offer or sell such shares, securities or other investments otherwise than in connection with the Placing. Accordingly, references in this Announcement to Placing Shares being issued, offered or placed should be read as including any issue, offering or placement of such shares in the Company to the Banks or any of their respective affiliates acting in such capacity. In addition, certain of the Banks or any of their respective affiliates may enter into financing arrangements (including swaps, warrants or contracts for difference) with investors in connection with which such Banks or any of their respective affiliates may from time to time acquire, hold or dispose of such securities of the Company, including the Placing Shares. None of the Banks or any of their respective affiliates intend to disclose the extent of any such investment or transactions otherwise than in accordance with any legal or regulatory obligation to do so.

The Placing Shares to be issued or sold pursuant to the Placing will not be admitted to trading on any stock exchange other than the London Stock Exchange.

Neither the content of the Company's website (or any other website) nor the content of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into or forms part of this Announcement.

This Announcement has been prepared for the purposes of complying with applicable law and regulation in the United Kingdom and the information disclosed may not be the same as that which would have been disclosed if this Announcement had been prepared in accordance with the laws and regulations of any jurisdiction outside the United Kingdom.

Solely for the purposes of the product governance requirements contained within: (a) EU Directive 2014/65/EU on markets in financial instruments, as amended ("MiFID II"); (B) Articles 9 and 10 of Commission Delegated Directive (EU) 2017/593 supplementing MiFID II; and (c) local implementing measures (together, the "MiFID II Product Governance Requirements"), and disclaiming all and any liability, whether arising in tort, contract or otherwise, which any 'manufacturer' (for the purposes of the MiFID II Product Governance Requirements) may otherwise have with respect thereto, the Placing Shares have been subject to a product approval process, which has determined that such Placing Shares are: (i) compatible with an end target market of retail investors and investors who meet the criteria of professional clients and eligible counterparties, each as defined in MiFID II; and (ii) eligible for distribution through all distribution channels as are permitted by MiFID II (the "Target Market Assessment"). Notwithstanding the Target Market Assessment, distributors should note that: the price of the Placing Shares may decline and investors could lose all or part of their investment; the Placing Shares offer no guaranteed income and no capital protection; and an investment in the Placing Shares is compatible only with investors who do not need a guaranteed income or capital protection, who (either alone or in conjunction with an appropriate financial or other adviser) are capable of evaluating the merits and risks of such an investment and who have sufficient resources to be able to bear any losses that may result therefrom. The Target Market Assessment is without prejudice to the requirements of any contractual, legal or regulatory selling restrictions in relation to the Placing. Furthermore, it is noted that, notwithstanding the Target Market Assessment, the Banks will only procure investors who meet the criteria of professional clients and eligible counterparties.

For the avoidance of doubt, the Target Market Assessment does not constitute: (a) an assessment of suitability or appropriateness for the purposes of MiFID II; or (b) a recommendation to any investor or group of investors to invest in, or purchase or take any other action whatsoever with respect to the Placing Shares. Each distributor is responsible for undertaking its own target market assessment in respect of the Placing Shares and determining appropriate distribution channels.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ROIFLFVVEVIDIII
Date   Source Headline
6th Apr 20213:30 pmRNSChange of Name
16th Mar 20217:00 amRNSFinal Results
11th Mar 20213:17 pmRNSHolding(s) in Company
5th Mar 20214:17 pmRNSHolding(s) in Company
3rd Mar 20219:24 amRNSHolding(s) in Company
26th Feb 20215:21 pmRNSHolding(s) in Company
26th Feb 20214:58 pmRNSTotal Voting Rights
17th Feb 20218:05 amRNSHolding(s) in Company
15th Feb 20214:22 pmRNSDirector/PDMR Shareholding
15th Feb 20211:59 pmRNSHolding(s) in Company
11th Feb 20217:00 amRNSResults of placing
10th Feb 20214:52 pmRNSProposed placing of new ordinary shares
10th Feb 20214:50 pmRNSAcquisition of ADEY
2nd Feb 20217:00 amRNSAcquisition of Nu-Heat and Trading Update
1st Feb 20213:57 pmRNSHolding(s) in Company
29th Jan 20215:32 pmRNSHolding(s) in Company
8th Jan 20218:50 amRNSHolding(s) in Company
14th Dec 20207:00 amRNSTrading Update
24th Nov 20208:25 amRNSHolding(s) in Company
17th Nov 20207:00 amRNSTrading Update
2nd Nov 20202:31 pmRNSDirector/PDMR Shareholding
2nd Nov 202010:05 amRNSBlock listing Interim Review
30th Oct 20204:26 pmRNSTotal Voting Rights
29th Oct 20202:32 pmRNSDirector/PDMR Shareholding
19th Oct 202010:09 amRNSHolding(s) in Company
7th Oct 202012:28 pmRNSHolding(s) in Company
6th Oct 202010:19 amRNSHolding(s) in Company
23rd Sep 202010:43 amRNSDirector Declaration
22nd Sep 20203:59 pmRNSDirector/PDMR Shareholding
17th Sep 20204:21 pmRNSDirector/PDMR Shareholding
15th Sep 20207:00 amRNSHalf-year Report
17th Jul 20204:26 pmRNSNon-Executive Director update
16th Jul 20209:37 amRNSHolding(s) in Company
7th Jul 20207:00 amRNSCOVID-19 Update
30th Jun 20202:41 pmRNSTotal Voting Rights
29th Jun 202012:59 pmRNSDirector Declaration
26th Jun 20204:19 pmRNSDirector/PDMR Shareholding
23rd Jun 20202:57 pmRNSDirector/PDMR Shareholding
23rd Jun 20208:28 amRNSHolding(s) in Company
22nd Jun 20204:14 pmRNSDirector/PDMR Shareholding
22nd Jun 20204:08 pmRNSDirector/PDMR Shareholding
22nd Jun 20203:06 pmRNSNon-Executive Director changes
18th Jun 20204:14 pmRNSDirector/PDMR Shareholding
17th Jun 20208:18 amRNSHolding(s) in Company
3rd Jun 202011:17 amRNSHolding(s) in Company
1st Jun 20201:24 pmRNSTotal Voting Rights
21st May 20203:05 pmRNSResult of AGM
15th May 202012:55 pmRNSHolding(s) in Company
13th May 202010:14 amRNSDirector/PDMR Shareholding
12th May 20204:01 pmRNSAnnual General Meeting 2020 - Change of Venue

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.